Buri, Pierre.
Buri, P.
VIAF ID: 28493739 ( Personal )
Permalink: http://viaf.org/viaf/28493739
Preferred Forms
-
- 100 1 _ ‡a Buri, P.
- 100 1 _ ‡a Buri, P.
-
-
- 100 1 0 ‡a Buri, P.
- 100 1 _ ‡a Buri, Pierre
-
- 100 1 _ ‡a Buri, Pierre
-
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
- 510 2 _ ‡a Laboratoire de Pharmacie Galénique ‡g Paris ‡e Affiliation
Works
Title | Sources |
---|---|
Application of medical imaging to pharmaceutical research : the example of gamma scintigraphy. I, Technological aspects | |
Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs | |
Chitosan as tear substitute : a wetting agent endowed with antimicrobial efficacy | |
Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol | |
Contribution à l'étude d'hydrogels à base de polymères de l'acide acrylique : application à la muqueuse nasale | |
Développement de nouvelles formes ophtalmiques à libération prolongée et évaluation de la durée de leur activité pharmacologique | |
Le diabète et les médicaments hypoglycémiants | |
Drug targeting : proceedings of the Symposium on Drug Targeting, held in Nyon, Switzerland, on 3-5 October 1984 | |
Du fard des Egyptiens aux pseudo-latex : évolution des formes médicamenteuses en ophtalmologie | |
Emploi des polymères dans l'élaboration de nouvelles formes médicamenteuses : recueil des conférences données lors du symposium tenu à l'Ecole de pharmacie de Genève, les 2 et 3 octobre 1980 : [symposium organisé par le Laboratoire de pharmacie galénique et de biopharmacie de l'Université de Genève et par Vifor S.A., Genève] | |
Enhancing effects of Azone® and 4-decyl-oxazolidin-2-one on ex vivo skin permeation | |
Étude de la perméabilité de la muqueuse orale : évaluation de différentes approches pour augmenter le passage des principes actifs | |
La Faculté des sciences côté chiffres, côté coeur | |
Formes pharmaceutiques nouvelles, c1985: | |
Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers | |
Gamma scintigraphy as tool for the evaluation of precorneal residence time : influence of the methodology | |
Une grande figure de la pharmacie nous a quitté : André Mirimanoff | |
Hommage à Paul Boymond | |
Human buccal absorption of codeine phosphate from a bioadhesive drug delivery device | |
In vivo evaluation of an indomethacin monolithic, extended zero-order release hard-gelatin capsule formulation based on saturated polyglycolysed glycerides | |
In vivo evaluation of dosage forms : application of gamma scintigraphy to non-enteral routes of administration | |
An investigation of the physical behaviour of moisture-activated mucoadhesive hydrogels upon contact with biological and non-biological substrates | |
Lipid extracting effect of ethanol on keratinized oral mucosa | |
Mucoadhesive semi-solid formulations for intraoral use containing sucralfate | |
Mucosal drug delivery, ocular | |
Muqueuse buccale et systèmes thérapeutiques bioadhésifs | |
Nasal absorption of metoclopramide administered to man | |
Nasal mucosa as an absorption barrier | |
Optimization of an ex vivo method for bioadhesion quantification | |
Permeability to fentanyl solutions and lipid composition of buccal epithelium surgically isolated versus heat-separated | |
Polyacrylate-based microparticles for sustained release of metoclopramide | |
Polyionic hydrogels as support for controlled release of nifedipine | |
Screening of potentially floating excipients for minitablets | |
A simple and rapid high-performance liquid chromatography method to quantify and evaluate the purity of nicotine in solution and in micro spheres | |
Simple method of in vitro diffusion of nicotine across porcine palatine mucosa | |
Topological distribution of a myristoylated peptide throughout the pig buccal mucosa during permeation |